Aller au contenu principal
Accès ouvert déclaré 2025 article

RP-HPLC method development, validation, and greenness profile evaluation: Concurrent quantification of telmisartan and atorvastatin calcium in combined pharmaceutical formulation

4Citations signalées — pas une note de qualité
6Institutions déclarées
3Pays d’affiliation déclarés

Résumé fourni par la source

Abstract Objectives When formulating new strategies, contemporary analysts prioritize sustainability. Research in green analytical chemistry aims to replace hazardous reagents with eco-friendly alternatives and minimize waste generation. This study employed a comprehensive assessment of greenness evaluation tools. A newly validated RP-HPLC method was subsequently applied for the quantitative analysis of Telmisartan (TEL) and Atorvastatin calcium (ATV Ca) in both pure form and tablet formulation. Methods The analysis utilized an HPLC-UV Youngling Acme 9000 system with an Inertsil ODS RP column (250 × 4.6 mm, 5 μm), operating at 250 nm. The mobile phase, a 60:40 (v/v) blend of acetonitrile and phosphate buffer (pH 3.5), was delivered at 1.50 mL min −1 under isocratic conditions. Telmisartan (TEL) and Atorvastatin calcium (ATV Ca) showed retention times of 2.75 and 5.33 min, respectively. Results Calibration curves were developed to evaluate the linearity of TEL (10–100 μg mL −1 ) and ATV Ca (2.5–25 μg mL −1 ), showing a high R 2 of 0.999. The LOD and LOQ for TEL were 0.41 μg mL −1 and 0.23 μg mL −1 , while for ATV Ca, they were 1.246 μg mL −1 and 0.695 μg mL −1 , with recoveries averaging 98.59%–99.95% and 99.57%–99.98%, respectively. Validation of the method was performed following ICH guidelines. Moreover, the greenness assessment of the HPLC method was assessed using the AES, NEMI, AGP, AGREE, ComplexMoGAPI, AMGS, and BAGI. Conclusion This study validates the newly developed method and evaluates its environmental impact with multiple evaluation tools, confirming its eco-friendly nature, highlighting its potential as a responsible choice for analysing the mixture, especially in quality control labs and the pharmaceutical industry.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref
RP-HPLC method development, validation, and greenness profile evaluation: Concurrent quantification of telmisartan and atorvastatin calcium in combined pharmaceutical formulation
Date Crossref
29/05/2026
Éditeur
Akademiai Kiado Zrt.
Type
journal-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude et ne compte pas comme une seconde source scientifique indépendante.

Institutions déclarées

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Sujets associés

Analytical Methods in PharmaceuticalsAnalytical Chemistry and ChromatographyChemistry and Chemical Engineering

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, ROR et la Banque mondiale, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune donnée externe enregistrée en base. Sources et limites.